Re: New shares issued?

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: New shares issued?

in response to

New shares issued?

masila

posted on Aug 07, 2018 11:01AM

Masila,

Thanks for noticing that SEDAR release and breaking it down for us. Yes, the mystery of Zenith continues for now. But not much longer I hope with the AGM in five weeks